glp-1 therapy hydration effects weight loss Stay hydrated while on GLP-1s! Here is why water is your best friend on this journey: 🚫 Muted Thirst: GLP-1's can dull your "I'm thirsty" signals, making it easy to get dehydrated GLP-1 Weight Loss Medications in

As for complications, women who'd discontinued a GLP-1 prior to pregnancy had a 30% higher risk of developing diabetes while pregnant, a 29% higher risk of blood pressure issues during pregnancy, and a 34% higher risk for preterm delivery, the study found

One study called the prevalence of optimal metabolic health alarmingly low, with only one in eight adults meeting the criteria

To media, w pogoni za klikniciem i emocj, dopisuj wasny kontekst, ktrego w danych po prostu nie ma

What causes the food noise to begin with

She was initially denied GLP-1 therapy

They can also be used to prevent and treat endocrine disorders or metabolic diseases such as polycystic ovary syndrome (PCOS), obesity, and non-alcoholic fatty liver disease (NAFLD) ( Figure 4 Effects on Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS), which is mainly manifested as sparse ovulation or non-ovulation, high levels of androgens, ovarian polycystic changes, obesity, and infertility, is the most common endocrine and metabolic disorder in women of childbearing age ( In women with PCOS, high concentrations of leptin have been reported to inhibit the expression of aromatase mRNA in granulosa cells, while the hyperandrogenic follicular environment in GCs was found to significantly reduce the expression of P450arom, which can convert androgens into estrogen, further increasing the levels of androgens and ultimately promoting follicular atresia ( Related studies have indicated a causal relationship between IR and all clinical symptoms of PCOS, with weight loss being shown to improve the reproductive function, hyperandrogenism and metabolism of women with PCOS ( Effects on Obesity Obesity, as a chronic recurrent disease, is known to increase the risk of developing T2MD, hypertension, dyslipidemias, CVDs, NAFLD, and other diseases, leading to a poor quality of life and increased mortality ( A randomized controlled trial found that GLP-1 mimics, such as exenatide and liraglutide, had a significant weight loss effect on obese/overweight patients without diabetes (172)